Compare RKDA & BBLG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RKDA | BBLG |
|---|---|---|
| Founded | 2002 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Agricultural Chemicals | Industrial Specialties |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1M | 1.2M |
| IPO Year | 2015 | 2014 |
| Metric | RKDA | BBLG |
|---|---|---|
| Price | $0.43 | $0.55 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 144.8K | ★ 201.6K |
| Earning Date | 05-07-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 66.92 | 45.13 |
| EPS | N/A | ★ N/A |
| Revenue | $4,858,000.00 | ★ $1,070,000,000.00 |
| Revenue This Year | $61.67 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.38 | $0.54 |
| 52 Week High | $6.71 | $2.89 |
| Indicator | RKDA | BBLG |
|---|---|---|
| Relative Strength Index (RSI) | 37.02 | 28.36 |
| Support Level | $0.38 | $0.54 |
| Resistance Level | $0.55 | $1.35 |
| Average True Range (ATR) | 0.04 | 0.03 |
| MACD | 0.00 | 0.02 |
| Stochastic Oscillator | 11.75 | 23.61 |
Arcadia Biosciences Inc is a company with science-based approaches to develop high value products and drive innovation in the consumer goods industry. The company has one operating and reportable segment, which derives revenue from the sale of Zola coconut water. The company's consumer brands in the food, beverage, and body care categories, and others. Its products include: Zola Coconut Water, and Agronomic Wheat Traits. Geographically, the company operates in United States, Argentina, India, and Canada. It derives maximum revenue from United States.
Bone Biologics Corp a medical device company that is currently focused on bone regeneration in spinal fusion using the recombinant human protein known as NELL-1. NELL-1 in combination with DBM, demineralized bone matrix, is an osteopromotive recombinant protein that provides target specific control over bone regeneration. It is a clinical-stage entity. The production and marketing of its products and ongoing research and development activities are subject to extensive regulation by numerous governmental authorities in the United States.